Alfredo Papa, Loris Riccardo Lopetuso, Laura Maria Minordi, Alessandra Di Veronica, Matteo Neri, Gianludovico Rapaccini, Antonio Gasbarrini, Valerio Papa
Journal: Expert review of gastroenterology & hepatology 2021;14(9):857-865
PMID: 32673498
INTRODUCTION
Enterocutaneous fistulas (ECFs) is a manifestation of penetrating Crohn's disease (CD) that is challenging to treat and has considerable morbidity and mortality rates.
AREAS COVERED
This review aims to explore the practical and updated principles for the optimal treatment of ECFs in CD patients.
EXPERT OPINION
Optimal ECF management requires a multidisciplinary approach. Treatment first includes fluid resuscitation and electrolyte rebalancing with control of sepsis by means of antibiotics and, when indicated, drainage of infected collections. Subsequent therapeutic steps include nutritional support, control of the fistula output and treatment of peristomal skin. Anti-TNF-α therapy seems to have limited utility only after sepsis is resolved and intestinal stenosis excluded. However, ECFs heal in only approximately one-third of cases without surgical intervention. Thus, correct surgical timing combined with adequate nutritional support, sepsis resolution and skin care is considered the appropriate preoperative setting.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.